FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.

2.

Which Risk Model Better Identifies High-Risk Smoldering MM?

3.

Cancer and HIV Vaccines Enter the Therapeutic Era

4.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

5.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot